Rewinding RX vs Lean Meds
An in-depth comparison of two leading GLP-1 Providers
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

Rewinding RX
Best for: coverage in all 50 states, which most of the register will not confirm
Visit Rewinding RX →
Lean Meds
Best for: knowing which pharmacy fills the vial — it names Belmar Pharmacy
Visit Lean Meds →Two GLP-1 Providers chasing the same patients, trading off price, geography and what lands in the box differently. On our scoring, Lean Meds starts at $79/mo, and Lean Meds finishes ahead, 9.3 to 4.9. What follows: the prices, what each plan actually covers, the six-dimension score, where each one is weak, and who should pick which.
Pricing
Rewinding RX
Pricing not publicly listed.
Lean Meds
Standing month-to-month rate. The advertised $69 is the 12-month prepay tier; 3-month is $76 and 6-month is $73.
Standing month-to-month rate. Prepay tiers: $105 for 3 months, $100 for 6, $95 for 12.
What’s included
Rewinding RX
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Lean Meds
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Score breakdown
Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.
Rewinding RX
4.9/10
Lean Meds
9.3/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
Features & Coverage
| Feature | Rewinding RX | Lean Meds |
|---|---|---|
| Starting Price | — | $79/mo |
| Features | ✓8 features | 7 features |
| States Available | 50 | 50 |
| Compounded | — | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
About Rewinding RX
One flat monthly rate covers any dose at Rewinding RX. Compounded GLP-1 therapy is presented as part of a wider biological-age-reversal program, sitting with NAD+ and functional-medicine protocols. What separates it is who signs off: reviews are MD-only, each case going to a fully licensed physician matched to the state the patient lives in, never a nurse or PA. It holds LegitScript certification and covers all 50 states.
Read our full Rewinding RX review →About Lean Meds
Titrating up does not raise the rate, which is flat and monthly: $79 to start on compounded semaglutide, $109 on compounded tirzepatide, the telehealth visit and shipping absorbed into both. Clinicians come from the OpenLoop Health network. Trinity HealthCare Supply, LLC operates the service and puts names to its five dispensing pharmacies as well as to the physicians who prescribe.
Read our full Lean Meds review →Pros & Cons
Rewinding RX
What we like
- The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
- The monthly figure covers medication, consult, shipping
- Coverage is published for all 50 states
- No FDA warning letter matched this operator when we searched our enforcement register
Watch-outs
- No price appears until the medical intake is complete, so the cost cannot be compared before health information is submitted
- No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
Lean Meds
What we like
- Semaglutide at $79 a month, 58% below the $189 median for the same drug and form across this register
- Tirzepatide at $109 a month, 59% below the $267 median for the same drug and form across this register
- Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
- The monthly figure covers medication, consult, shipping
- Coverage is published for all 50 states
- Names 5 dispensing pharmacies, which most sellers in this register do not do
- No FDA warning letter matched this operator when we searched our enforcement register
Watch-outs
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Lean Meds takes it, 9.3 against 4.9, and it is especially strong on knowing which pharmacy fills the vial — it names Belmar Pharmacy. Rewinding RX is no weak second and may fit you better on coverage in all 50 states, which most of the register will not confirm.
Choose Rewinding RX if…
You want coverage in all 50 states, which most of the register will not confirm.
Choose Lean Meds if…
You want knowing which pharmacy fills the vial — it names Belmar Pharmacy and an opening price near $79 a month.
Ready to start? Vetted GLP-1 providers
Vetted telehealth providers that prescribe GLP-1 online.
No insurance needed · vetted by our editors
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
SkinnyRx
Starting below a standard dose, with microdose tiers
From $149.25/mo
Get started →YourEra
Semaglutide at $99/month, 63% under the register median
From $99/mo
Get started →Gala
Moving between compounded and brand without changing seller
From $129/mo
Get started →Rewinding RX vs Lean Meds: FAQ
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring Rewinding RX and Lean Meds head-to-heads in the same category.
- Rewinding RX vs Trimi Health
- Rewinding RX vs Embody
- Rewinding RX vs He & She MD
- Lean Meds vs NextMeds
- Lean Meds vs bmiMD
- Lean Meds vs CoreAge Rx
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.